Anaplastic large cell lymphoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (22 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Anaplastic large cell lymphoma}} | {{Anaplastic large cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}}, {{kakbar}}; {{GRR}} {{Nat}} | ||
==Overview== | ==Overview== | ||
The predominant therapy for anaplastic lymphoma is [[chemotherapy]]. Adjunctive [[radiotherapy]], [[stem cell transplantation]] and [[surgery]] may be required. The optimal therapy for anaplastic large cell lymphoma depends on the type and extent of anaplastic large cell lymphoma. | The predominant therapy for anaplastic lymphoma is [[chemotherapy]]. Adjunctive [[radiotherapy]], [[stem cell transplantation]], and [[surgery]] may be required. The optimal therapy for anaplastic large cell lymphoma depends on the type and extent of anaplastic large cell lymphoma. | ||
==Medical Therapy== | ==Medical Therapy== | ||
* The optimal therapy for anaplastic large cell lymphoma depends on: | * The optimal therapy for anaplastic large cell lymphoma depends on: | ||
:* Type of anaplastic large cell lymphoma | :* Type of anaplastic large cell lymphoma | ||
:* Extent of anaplastic large cell lymphoma | :* Extent of anaplastic large cell lymphoma | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
|+ '''Treatment for anaplastic large cell lymphoma | |+ '''Treatment for anaplastic large cell lymphoma''' | ||
! style="background: #4479BA;; color:#FFF;" | Type | ! style="background: #4479BA;; color:#FFF;" | Type | ||
! style="background: #4479BA;; color:#FFF;" | Chemotherapy | ! style="background: #4479BA;; color:#FFF;" | Chemotherapy | ||
| Line 36: | Line 36: | ||
| style="padding: center; padding: 5px 5px; background: #F5F5F5;" | -------- | | style="padding: center; padding: 5px 5px; background: #F5F5F5;" | -------- | ||
|} | |} | ||
===Chemotherapy | ===Chemotherapy=== | ||
* Anaplastic large cell lymphoma usually responds well to chemotherapy, so it often has a good prognosis | * Anaplastic large cell lymphoma usually responds well to chemotherapy, so it often has a good prognosis. | ||
* | * Anaplastic large cell lymphoma is treated with the same combinations of chemotherapy drugs used to treat other aggressive lymphomas. | ||
* Drug Regimen: (CHOP) [[Cyclophosphamide]] {{and}} [[Doxorubicin]] {{and}} [[Vincristine]] {{and}} [[Prednisone]] | * Drug Regimen: ([[CHOP]]) [[Cyclophosphamide]] {{and}} [[Doxorubicin]] {{and}} [[Vincristine]] {{and}} [[Prednisone]]<ref name="pmid29516333">{{cite journal| author=Vu K, Ai W| title=Update on the Treatment of Anaplastic Large Cell Lymphoma. | journal=Curr Hematol Malig Rep | year= 2018 | volume= 13 | issue= 2 | pages= 135-141 | pmid=29516333 | doi=10.1007/s11899-018-0436-z | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29516333 }} </ref> | ||
===Radiation therapy=== | |||
* Radiation therapy is most often given after chemotherapy | * Radiation therapy is most often given after chemotherapy.<ref name="JulieMann2017">{{cite journal|last1=Julie|first1=D.A.|last2=Mann|first2=J.M.|last3=Wu|first3=X.|last4=Nagar|first4=H.|title=Role of Adjuvant Radiotherapy for Early-Stage Anaplastic Large Cell Lymphoma: Analysis of the National Cancer Database|journal=International Journal of Radiation Oncology*Biology*Physics|volume=99|issue=2|year=2017|pages=S141|issn=03603016|doi=10.1016/j.ijrobp.2017.06.327}}</ref> | ||
:[[External beam radiotherapy|External beam radiation therapy]] may be used: | |||
:* When the lymphoma cells are only in one area of the lymph nodes (stage I primary systemic anaplastic large cell lymphoma) | :* When the lymphoma cells are only in one area of the lymph nodes (stage I primary systemic anaplastic large cell lymphoma). | ||
:* For localized skin lesions in primary cutaneous anaplastic large cell lymphoma | :* For localized skin lesions in primary cutaneous anaplastic large cell lymphoma. | ||
===Stem cell transplant<ref name= | |||
===Stem cell transplant=== | |||
* A [[stem cell transplant]] may be offered to patients with anaplastic large cell lymphoma who relapse after initial treatment.<ref name="pmid10929023">{{cite journal| author=Deconinck E, Lamy T, Foussard C, Gaillard F, Delwail V, Colombat P et al.| title=Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial. | journal=Br J Haematol | year= 2000 | volume= 109 | issue= 4 | pages= 736-42 | pmid=10929023 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10929023 }} </ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 53: | Line 54: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 12:45, 11 April 2019
|
Anaplastic large cell lymphoma Microchapters |
|
Differentiating Anaplastic large cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anaplastic large cell lymphoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Anaplastic large cell lymphoma medical therapy |
|
Directions to Hospitals Treating Anaplastic large cell lymphoma |
|
Risk calculators and risk factors for Anaplastic large cell lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Kamal Akbar, M.D.[3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
The predominant therapy for anaplastic lymphoma is chemotherapy. Adjunctive radiotherapy, stem cell transplantation, and surgery may be required. The optimal therapy for anaplastic large cell lymphoma depends on the type and extent of anaplastic large cell lymphoma.
Medical Therapy
- The optimal therapy for anaplastic large cell lymphoma depends on:
- Type of anaplastic large cell lymphoma
- Extent of anaplastic large cell lymphoma
| Type | Chemotherapy | Radiotherapy | Stem cell transplant | Surgery |
|---|---|---|---|---|
| Primary cutaneous anaplastic large cell lymphoma |
|
|
-------- |
|
| Primary systemic anaplastic large cell lymphoma |
|
|
|
-------- |
Chemotherapy
- Anaplastic large cell lymphoma usually responds well to chemotherapy, so it often has a good prognosis.
- Anaplastic large cell lymphoma is treated with the same combinations of chemotherapy drugs used to treat other aggressive lymphomas.
- Drug Regimen: (CHOP) Cyclophosphamide AND Doxorubicin AND Vincristine AND Prednisone[1]
Radiation therapy
- Radiation therapy is most often given after chemotherapy.[2]
- External beam radiation therapy may be used:
- When the lymphoma cells are only in one area of the lymph nodes (stage I primary systemic anaplastic large cell lymphoma).
- For localized skin lesions in primary cutaneous anaplastic large cell lymphoma.
Stem cell transplant
- A stem cell transplant may be offered to patients with anaplastic large cell lymphoma who relapse after initial treatment.[3]
References
- ↑ Vu K, Ai W (2018). "Update on the Treatment of Anaplastic Large Cell Lymphoma". Curr Hematol Malig Rep. 13 (2): 135–141. doi:10.1007/s11899-018-0436-z. PMID 29516333.
- ↑ Julie, D.A.; Mann, J.M.; Wu, X.; Nagar, H. (2017). "Role of Adjuvant Radiotherapy for Early-Stage Anaplastic Large Cell Lymphoma: Analysis of the National Cancer Database". International Journal of Radiation Oncology*Biology*Physics. 99 (2): S141. doi:10.1016/j.ijrobp.2017.06.327. ISSN 0360-3016.
- ↑ Deconinck E, Lamy T, Foussard C, Gaillard F, Delwail V, Colombat P; et al. (2000). "Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial". Br J Haematol. 109 (4): 736–42. PMID 10929023.